title: Response to the paper entitled clinical and therapeutic impact of 18F-FDG PET/CT whole-body acquisition including lower limbs in patients with malignant melanoma.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Davidson
authors.forename: Francis
authors.initials: F
authors.lastname: Sundram
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D035002:Lower Extremity / Q000000981:diagnostic imaging*; D008545:Melanoma / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000628:therapy*; D049268:Positron-Emission Tomography / Q000379:methods*; D014057:Tomography, X-Ray Computed / Q000379:methods*; D016896:Treatment Outcome; D051598:Whole Body Imaging
chemical_list: D019788:Fluorodeoxyglucose F18